S2-E62.3 – 2021-YIR: Patient-Advocate Initiated and Sponsored SUNN Study

S2-E62.3 - SurfingNASH's 2021 NAFLD year-in-review Covers the Patient-Advocate Initiated and Sponsored SUNN Study
Wayne Eskridge joins the Surfers to discuss the patient-initiated SUNN study and the significance not only of the results but also of the idea that a patient advocacy group could foster this kind of trial.

This conversation is part of SurfingNASH’s 2021 NAFLD Year-In-Review. Fatty Liver Foundation Founder and President Wayne Eskridge joins Louise Campbell and Roger Green to discuss the recently-completed SUNN study that was initiated and shepherded by FLF. Wayne discusses study results and the challenges for an orgganization like FLF in conducting this kind of study.

[415]

Wayne focuses intently on what the study tells us about prevalence of disease in the US. Like the San Antonio Military Medical Center research that Stephen Harrison et al. authored in 2011 and 2021, the study suggested a far higher rate of NAFLD and NASH than typical estimates project, with a NASH rate of 17% in the study population! He also discusses frustrations with the existing order and prior estimates that motivated him to champion the study and some specific issues in actually conducting, analyzing and publishing it. Finally, he discusses the far larger, more ambitious SUNN 2 study currently in the works.

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.